Global Personalized Medicines Market Research Report 2023

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.

The global Personalized Medicines market was valued at US$ 291120 million in 2022 and is anticipated to reach US$ 540120 million by 2029, witnessing a CAGR of 10.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.

This report aims to provide a comprehensive presentation of the global market for Personalized Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines.

The Personalized Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Personalized Medicines market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 PM Diagnostics

1.2.3 PM Therapeutics

1.2.4 Personalized Medical Care

1.2.5 Personalized Nutrition & Wellness

1.3 Market by Application

1.3.1 Global Personalized Medicines Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Dietary Care Centers

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Personalized Medicines Market Perspective (2018-2029)

2.2 Personalized Medicines Growth Trends by Region

2.2.1 Global Personalized Medicines Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Personalized Medicines Historic Market Size by Region (2018-2023)

2.2.3 Personalized Medicines Forecasted Market Size by Region (2024-2029)

2.3 Personalized Medicines Market Dynamics

2.3.1 Personalized Medicines Industry Trends

2.3.2 Personalized Medicines Market Drivers

2.3.3 Personalized Medicines Market Challenges

2.3.4 Personalized Medicines Market Restraints

3.1 Global Top Personalized Medicines Players by Revenue

3.1.1 Global Top Personalized Medicines Players by Revenue (2018-2023)

3.1.2 Global Personalized Medicines Revenue Market Share by Players (2018-2023)

3.2 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Personalized Medicines Revenue

3.4 Global Personalized Medicines Market Concentration Ratio

3.4.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2022

3.5 Personalized Medicines Key Players Head office and Area Served

3.6 Key Players Personalized Medicines Product Solution and Service

3.7 Date of Enter into Personalized Medicines Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Personalized Medicines Historic Market Size by Type (2018-2023)

4.2 Global Personalized Medicines Forecasted Market Size by Type (2024-2029)

5.1 Global Personalized Medicines Historic Market Size by Application (2018-2023)

5.2 Global Personalized Medicines Forecasted Market Size by Application (2024-2029)

6.1 North America Personalized Medicines Market Size (2018-2029)

6.2 North America Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Personalized Medicines Market Size by Country (2018-2023)

6.4 North America Personalized Medicines Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Personalized Medicines Market Size (2018-2029)

7.2 Europe Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Personalized Medicines Market Size by Country (2018-2023)

7.4 Europe Personalized Medicines Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Personalized Medicines Market Size (2018-2029)

8.2 Asia-Pacific Personalized Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Personalized Medicines Market Size by Region (2018-2023)

8.4 Asia-Pacific Personalized Medicines Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Personalized Medicines Market Size (2018-2029)

9.2 Latin America Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Personalized Medicines Market Size by Country (2018-2023)

9.4 Latin America Personalized Medicines Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Personalized Medicines Market Size (2018-2029)

10.2 Middle East & Africa Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Personalized Medicines Market Size by Country (2018-2023)

10.4 Middle East & Africa Personalized Medicines Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 3G Biotech

11.1.1 3G Biotech Company Detail

11.1.2 3G Biotech Business Overview

11.1.3 3G Biotech Personalized Medicines Introduction

11.1.4 3G Biotech Revenue in Personalized Medicines Business (2018-2023)

11.1.5 3G Biotech Recent Development

11.2 Quest Diagnostics

11.2.1 Quest Diagnostics Company Detail

11.2.2 Quest Diagnostics Business Overview

11.2.3 Quest Diagnostics Personalized Medicines Introduction

11.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2018-2023)

11.2.5 Quest Diagnostics Recent Development

11.3 Laboratory Corporation of America

11.3.1 Laboratory Corporation of America Company Detail

11.3.2 Laboratory Corporation of America Business Overview

11.3.3 Laboratory Corporation of America Personalized Medicines Introduction

11.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2018-2023)

11.3.5 Laboratory Corporation of America Recent Development

11.4 Abbott

11.4.1 Abbott Company Detail

11.4.2 Abbott Business Overview

11.4.3 Abbott Personalized Medicines Introduction

11.4.4 Abbott Revenue in Personalized Medicines Business (2018-2023)

11.4.5 Abbott Recent Development

11.5 Agendia NV

11.5.1 Agendia NV Company Detail

11.5.2 Agendia NV Business Overview

11.5.3 Agendia NV Personalized Medicines Introduction

11.5.4 Agendia NV Revenue in Personalized Medicines Business (2018-2023)

11.5.5 Agendia NV Recent Development

11.6 Asuragen Inc

11.6.1 Asuragen Inc Company Detail

11.6.2 Asuragen Inc Business Overview

11.6.3 Asuragen Inc Personalized Medicines Introduction

11.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2018-2023)

11.6.5 Asuragen Inc Recent Development

11.7 Becton Dickinson

11.7.1 Becton Dickinson Company Detail

11.7.2 Becton Dickinson Business Overview

11.7.3 Becton Dickinson Personalized Medicines Introduction

11.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2018-2023)

11.7.5 Becton Dickinson Recent Development

11.8 CardioDx Inc.

11.8.1 CardioDx Inc. Company Detail

11.8.2 CardioDx Inc. Business Overview

11.8.3 CardioDx Inc. Personalized Medicines Introduction

11.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2018-2023)

11.8.5 CardioDx Inc. Recent Development

11.9 Foundation Medicine

11.9.1 Foundation Medicine Company Detail

11.9.2 Foundation Medicine Business Overview

11.9.3 Foundation Medicine Personalized Medicines Introduction

11.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2018-2023)

11.9.5 Foundation Medicine Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Detail

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Personalized Medicines Introduction

11.10.4 Qiagen Revenue in Personalized Medicines Business (2018-2023)

11.10.5 Qiagen Recent Development

11.11 Siemens Healthcare

11.11.1 Siemens Healthcare Company Detail

11.11.2 Siemens Healthcare Business Overview

11.11.3 Siemens Healthcare Personalized Medicines Introduction

11.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2018-2023)

11.11.5 Siemens Healthcare Recent Development

11.12 Amgen

11.12.1 Amgen Company Detail

11.12.2 Amgen Business Overview

11.12.3 Amgen Personalized Medicines Introduction

11.12.4 Amgen Revenue in Personalized Medicines Business (2018-2023)

11.12.5 Amgen Recent Development

11.13 Bristol-Myers Squibb

11.13.1 Bristol-Myers Squibb Company Detail

11.13.2 Bristol-Myers Squibb Business Overview

11.13.3 Bristol-Myers Squibb Personalized Medicines Introduction

11.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2018-2023)

11.13.5 Bristol-Myers Squibb Recent Development

11.14 GE Healthcare

11.14.1 GE Healthcare Company Detail

11.14.2 GE Healthcare Business Overview

11.14.3 GE Healthcare Personalized Medicines Introduction

11.14.4 GE Healthcare Revenue in Personalized Medicines Business (2018-2023)

11.14.5 GE Healthcare Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Detail

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Personalized Medicines Introduction

11.15.4 Pfizer Revenue in Personalized Medicines Business (2018-2023)

11.15.5 Pfizer Recent Development

11.16 Sanofi

11.16.1 Sanofi Company Detail

11.16.2 Sanofi Business Overview

11.16.3 Sanofi Personalized Medicines Introduction

11.16.4 Sanofi Revenue in Personalized Medicines Business (2018-2023)

11.16.5 Sanofi Recent Development

11.17 23andMe

11.17.1 23andMe Company Detail

11.17.2 23andMe Business Overview

11.17.3 23andMe Personalized Medicines Introduction

11.17.4 23andMe Revenue in Personalized Medicines Business (2018-2023)

11.17.5 23andMe Recent Development

11.18 Illumina

11.18.1 Illumina Company Detail

11.18.2 Illumina Business Overview

11.18.3 Illumina Personalized Medicines Introduction

11.18.4 Illumina Revenue in Personalized Medicines Business (2018-2023)

11.18.5 Illumina Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Personalized Medicines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of PM Diagnostics

    Table 3. Key Players of PM Therapeutics

    Table 4. Key Players of Personalized Medical Care

    Table 5. Key Players of Personalized Nutrition & Wellness

    Table 6. Global Personalized Medicines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Personalized Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Personalized Medicines Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Personalized Medicines Market Share by Region (2018-2023)

    Table 10. Global Personalized Medicines Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Personalized Medicines Market Share by Region (2024-2029)

    Table 12. Personalized Medicines Market Trends

    Table 13. Personalized Medicines Market Drivers

    Table 14. Personalized Medicines Market Challenges

    Table 15. Personalized Medicines Market Restraints

    Table 16. Global Personalized Medicines Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Personalized Medicines Market Share by Players (2018-2023)

    Table 18. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2022)

    Table 19. Ranking of Global Top Personalized Medicines Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Personalized Medicines Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Personalized Medicines Product Solution and Service

    Table 23. Date of Enter into Personalized Medicines Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Personalized Medicines Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Personalized Medicines Revenue Market Share by Type (2018-2023)

    Table 27. Global Personalized Medicines Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Personalized Medicines Revenue Market Share by Type (2024-2029)

    Table 29. Global Personalized Medicines Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Personalized Medicines Revenue Market Share by Application (2018-2023)

    Table 31. Global Personalized Medicines Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Personalized Medicines Revenue Market Share by Application (2024-2029)

    Table 33. North America Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Personalized Medicines Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Personalized Medicines Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Personalized Medicines Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Personalized Medicines Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Personalized Medicines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Personalized Medicines Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Personalized Medicines Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Personalized Medicines Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Personalized Medicines Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Personalized Medicines Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Personalized Medicines Market Size by Country (2024-2029) & (US$ Million)

    Table 48. 3G Biotech Company Detail

    Table 49. 3G Biotech Business Overview

    Table 50. 3G Biotech Personalized Medicines Product

    Table 51. 3G Biotech Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 52. 3G Biotech Recent Development

    Table 53. Quest Diagnostics Company Detail

    Table 54. Quest Diagnostics Business Overview

    Table 55. Quest Diagnostics Personalized Medicines Product

    Table 56. Quest Diagnostics Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 57. Quest Diagnostics Recent Development

    Table 58. Laboratory Corporation of America Company Detail

    Table 59. Laboratory Corporation of America Business Overview

    Table 60. Laboratory Corporation of America Personalized Medicines Product

    Table 61. Laboratory Corporation of America Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 62. Laboratory Corporation of America Recent Development

    Table 63. Abbott Company Detail

    Table 64. Abbott Business Overview

    Table 65. Abbott Personalized Medicines Product

    Table 66. Abbott Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 67. Abbott Recent Development

    Table 68. Agendia NV Company Detail

    Table 69. Agendia NV Business Overview

    Table 70. Agendia NV Personalized Medicines Product

    Table 71. Agendia NV Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 72. Agendia NV Recent Development

    Table 73. Asuragen Inc Company Detail

    Table 74. Asuragen Inc Business Overview

    Table 75. Asuragen Inc Personalized Medicines Product

    Table 76. Asuragen Inc Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 77. Asuragen Inc Recent Development

    Table 78. Becton Dickinson Company Detail

    Table 79. Becton Dickinson Business Overview

    Table 80. Becton Dickinson Personalized Medicines Product

    Table 81. Becton Dickinson Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 82. Becton Dickinson Recent Development

    Table 83. CardioDx Inc. Company Detail

    Table 84. CardioDx Inc. Business Overview

    Table 85. CardioDx Inc. Personalized Medicines Product

    Table 86. CardioDx Inc. Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 87. CardioDx Inc. Recent Development

    Table 88. Foundation Medicine Company Detail

    Table 89. Foundation Medicine Business Overview

    Table 90. Foundation Medicine Personalized Medicines Product

    Table 91. Foundation Medicine Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 92. Foundation Medicine Recent Development

    Table 93. Qiagen Company Detail

    Table 94. Qiagen Business Overview

    Table 95. Qiagen Personalized Medicines Product

    Table 96. Qiagen Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 97. Qiagen Recent Development

    Table 98. Siemens Healthcare Company Detail

    Table 99. Siemens Healthcare Business Overview

    Table 100. Siemens Healthcare Personalized Medicines Product

    Table 101. Siemens Healthcare Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 102. Siemens Healthcare Recent Development

    Table 103. Amgen Company Detail

    Table 104. Amgen Business Overview

    Table 105. Amgen Personalized Medicines Product

    Table 106. Amgen Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 107. Amgen Recent Development

    Table 108. Bristol-Myers Squibb Company Detail

    Table 109. Bristol-Myers Squibb Business Overview

    Table 110. Bristol-Myers Squibb Personalized Medicines Product

    Table 111. Bristol-Myers Squibb Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 112. Bristol-Myers Squibb Recent Development

    Table 113. GE Healthcare Company Detail

    Table 114. GE Healthcare Business Overview

    Table 115. GE Healthcare Personalized Medicines Product

    Table 116. GE Healthcare Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 117. GE Healthcare Recent Development

    Table 118. Pfizer Company Detail

    Table 119. Pfizer Business Overview

    Table 120. Pfizer Personalized Medicines Product

    Table 121. Pfizer Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 122. Pfizer Recent Development

    Table 123. Sanofi Company Detail

    Table 124. Sanofi Business Overview

    Table 125. Sanofi Personalized Medicines Product

    Table 126. Sanofi Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 127. Sanofi Recent Development

    Table 128. 23andMe Company Detail

    Table 129. 23andMe Business Overview

    Table 130. 23andMe Personalized Medicines Product

    Table 131. 23andMe Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 132. 23andMe Recent Development

    Table 133. Illumina Company Detail

    Table 134. Illumina Business Overview

    Table 135. Illumina Personalized Medicines Product

    Table 136. Illumina Revenue in Personalized Medicines Business (2018-2023) & (US$ Million)

    Table 137. Illumina Recent Development

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Personalized Medicines Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Personalized Medicines Market Share by Type: 2022 VS 2029

    Figure 3. PM Diagnostics Features

    Figure 4. PM Therapeutics Features

    Figure 5. Personalized Medical Care Features

    Figure 6. Personalized Nutrition & Wellness Features

    Figure 7. Global Personalized Medicines Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Personalized Medicines Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Pharmacies Case Studies

    Figure 10. Retail Pharmacies Case Studies

    Figure 11. Dietary Care Centers Case Studies

    Figure 12. Others Case Studies

    Figure 13. Personalized Medicines Report Years Considered

    Figure 14. Global Personalized Medicines Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Personalized Medicines Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Personalized Medicines Market Share by Region: 2022 VS 2029

    Figure 17. Global Personalized Medicines Market Share by Players in 2022

    Figure 18. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Personalized Medicines Revenue in 2022

    Figure 20. North America Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Personalized Medicines Market Share by Country (2018-2029)

    Figure 22. United States Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Personalized Medicines Market Share by Country (2018-2029)

    Figure 26. Germany Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Personalized Medicines Market Share by Region (2018-2029)

    Figure 34. China Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Personalized Medicines Market Share by Country (2018-2029)

    Figure 42. Mexico Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Personalized Medicines Market Share by Country (2018-2029)

    Figure 46. Turkey Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Personalized Medicines Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. 3G Biotech Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 49. Quest Diagnostics Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 50. Laboratory Corporation of America Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 51. Abbott Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 52. Agendia NV Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 53. Asuragen Inc Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 54. Becton Dickinson Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 55. CardioDx Inc. Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 56. Foundation Medicine Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 57. Qiagen Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 58. Siemens Healthcare Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 59. Amgen Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 61. GE Healthcare Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 62. Pfizer Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 63. Sanofi Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 64. 23andMe Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 65. Illumina Revenue Growth Rate in Personalized Medicines Business (2018-2023)

    Figure 66. Bottom-up and Top-down Approaches for This Report

    Figure 67. Data Triangulation

    Figure 68. Key Executives Interviewed